Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Biotech
Applied Tx’s pediatric rare disease prosect hits another snag
The FDA needs more time to review Applied's application for rare disease prospect govorestat, sending the biotech's stock tumbling after hours.
Gabrielle Masson
Mar 29, 2024 10:21am
Nanoscope eyes market after phase 2b retinal disease data drop
Mar 26, 2024 7:00am
Crinetics pads case for oral hormone disorder drug
Mar 19, 2024 9:30am
Oxford Nanopore, SeqOne ink rare disease diagnostic partnership
Mar 15, 2024 3:10pm
AstraZeneca inks $800M buyout to snag phase 3 rare disease drug
Mar 14, 2024 9:47am
Biogen's top dealmaker is keen on rare disease meds
Mar 5, 2024 10:20am